Daratumumab: new treatment option for relapsed and refractory multiple myeloma

Daratumumab is a human monoclonal antibody that binds to the CD38 protein responsible for receptor mediated adhesion, signalling and enzymatic activity. This protein is expressed at high levels on the surface of multiple myeloma tumour cells.

Darzalex (daratumumab) is licensed for the treatment of adult patients with relapsed and refractory multiple myeloma, whose prior therapy included a proteasome inhibitor and an immunomodulatory agent and who have demonstrated disease progression on the last therapy.

Further information
View Darzalex drug record
Summary of Product Characteristics
Manufacturer: Janssen-Cilag

The recommended dose of daratumumab is 16mg/kg administered as an intravenous infusion over 60 minutes ever week for the first 8 weeks. From weeks 9 to 24, the dosing interval is increased to every 2 weeks, followed by every 4 weeks from week 25 onwards. Treatment should be continued until disease progression or unacceptable toxicity. 

To reduce the risk of infusion reactions, patients must receive premedication with an antihistamine, corticosteroid and paracetamol before each infusion. Commonly reported adverse events reported in clinical trials were infections, blood dyscrasias, decreased appetite. respiratory symptoms, pain, chills, fever and fatigue.

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.